We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
-8.43%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$514M
AUM Growth
-$86.2M
Cap. Flow
-$11.8M
Cap. Flow %
-2.3%
Top 10 Hldgs %
22.06%
Holding
136
New
15
Increased
60
Reduced
35
Closed
13

Top Buys

Rank Stock Value
1
CNMD icon
CONMED
CNMD
+$7.87M
2
GDRX icon
GoodRx Holdings
GDRX
+$6.71M
3
IOVA icon
Iovance Biotherapeutics
IOVA
+$6.43M
4
ACAD icon
Acadia Pharmaceuticals
ACAD
+$5.7M
5
PODD icon
Insulet
PODD
+$5.42M

Top Sells

Rank Stock Value
1
TMCI icon
Treace Medical Concepts
TMCI
+$9.71M
2
INSP icon
Inspire Medical Systems
INSP
+$7.79M
3
AGTI
Agiliti Inc
AGTI
+$7.74M
4
TVTX icon
Travere Therapeutics
TVTX
+$6.69M
5
AMLX icon
Amylyx Pharmaceuticals
AMLX
+$6.63M

Sector Composition

Rank Sector Weight
1 Healthcare 97.41%
2 Industrials 2.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GILD icon
76
Gilead Sciences
GILD
$162B
$2.86M 0.56%
38,150
+5,468
+17% +$421K
DHR icon
77
Danaher
DHR
$138B
$2.72M 0.53%
12,380
– –
SRRK icon
78
Scholar Rock
SRRK
$5.63B
$2.2M 0.43%
310,398
+64,663
+26% +$434K
SRPT icon
79
Sarepta Therapeutics
SRPT
$1.61B
$2.18M 0.43%
18,006
-34,443
-66% -$3.89M
ANNX icon
80
Annexon
ANNX
$850M
$2.12M 0.41%
898,785
+224,156
+33% +$678K
TSBX
81
DELISTED
Turnstone Biologics
TSBX
$2.04M 0.4%
+517,648
New +$4.61M
SGEN
82
DELISTED
Seagen Inc. Common Stock
SGEN
$1.95M 0.38%
9,210
+1,195
+15% +$239K
STAA icon
83
STAAR Surgical
STAA
$1.21B
$1.89M 0.37%
+47,000
New +$2.2M
PMVP icon
84
PMV Pharmaceuticals
PMVP
$59.2M
$1.87M 0.36%
303,824
-28,426
-9% -$195K
MGNX icon
85
MacroGenics
MGNX
$241M
$1.8M 0.35%
387,001
+34,504
+10% +$172K
XBI icon
86
State Street SPDR S&P Biotech ETF
XBI
$9.65B
$1.8M 0.35%
24,675
+6,643
+37% +$531K
AVIR icon
87
Atea Pharmaceuticals
AVIR
$374M
$1.8M 0.35%
600,461
+98,924
+20% +$337K
ALLK
88
DELISTED
Allakos
ALLK
$1.75M 0.34%
770,132
+335,822
+77% +$1.25M
ITOS
89
DELISTED
iTeos Therapeutics
ITOS
$1.7M 0.33%
155,075
+8,499
+6% +$109K
AZN icon
90
AstraZeneca
AZN
$239B
$1.68M 0.33%
12,410
+1,797
+17% +$245K
VSTM icon
91
Verastem
VSTM
$510M
$1.65M 0.32%
+203,327
New +$1.95M
MRNA icon
92
Moderna
MRNA
$22.6B
$1.55M 0.3%
15,000
+2,172
+17% +$242K
STRO icon
93
Sutro Biopharma
STRO
$407M
$1.5M 0.29%
43,234
+3,169
+8% +$138K
EFTR
94
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$1.43M 0.28%
95,306
– –
EYPT icon
95
EyePoint Inc
EYPT
$1.03B
$1.41M 0.27%
176,080
-135,197
-43% -$1.48M
GBIO
96
DELISTED
Generation Bio
GBIO
$1.35M 0.26%
35,674
– –
AMLX icon
97
Amylyx Pharmaceuticals
AMLX
$2.22B
$1.35M 0.26%
73,655
-313,655
-81% -$6.63M
RLYB icon
98
Rallybio
RLYB
$84.3M
$1.27M 0.25%
46,995
– –
BCAB icon
99
BioAtla
BCAB
$5.66M
$1.2M 0.23%
14,121
+2,991
+27% +$381K
ILMN icon
100
Illumina
ILMN
$30.8B
$865K 0.17%
6,476
+892
+16% +$147K
2 3
4
5 6

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q3 2023 Portfolio in Review

As of Q3 2023, Sectoral Asset Management held 136 positions worth $514M, down 14% from $600M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Sectoral Asset Management's Q3 2023 filing shows 15 new, 60 increased, 35 reduced and 13 closed positions. Its largest new stake was GoodRx Holdings: 1,007,000 shares worth $5.67M. The largest sale was Treace Medical Concepts, an estimated $9.71M.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, up from 96% a quarter earlier, followed by Industrials.

  • Sectoral Asset Management's largest Q3 2023 buy was GoodRx Holdings: 1,007,000 shares worth $5.67M.
  • Sectoral Asset Management added most to CONMED in Q3 2023, an estimated $7.87M increase.
  • Sectoral Asset Management's biggest Q3 2023 reduction was Amylyx Pharmaceuticals, cutting an estimated $6.63M.
  • Sectoral Asset Management fully exited Treace Medical Concepts in Q3 2023, selling an estimated $9.71M.
  • Sectoral Asset Management's ten largest holdings make up 22% of its $514M portfolio in Q3 2023.
  • Sectoral Asset Management opened 15 new positions and closed 13 in Q3 2023.
  • Sectoral Asset Management's portfolio value fell 14% quarter-over-quarter to $514M.

Based on Sectoral Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.